Sam Boake

@daaapollo908 The MC is $120M. So $20M would be 15% to 20%

$IXHL This will rocket share price!!!!!!!!! The program was announced on August 22, 2025.The company says actual repurchases (timing & amount) will depend on market conditions, available capital, and other factors. GlobeNewswire+1 The $20M buyback is nearly 60% of market cap).

#IncannexHealthcare is pleased to report positive data from its Phase 2 #clinicaltrial of PSX-001 (formerly Psi-GAD), a psilocybin-assisted #psychotherapy treatment for Generalised Anxiety Disorder (GAD). Read more: bit.ly/4lJZMK8 $IXHL #ClinicalTrials #IXHL

$IXHL A great summary and opinion piece - I agree. Results are clinically significant & financial position is now very strong. @ASX_IHL will find a true valuation soon at significant higher prices. claude.ai/public/artifac…

$IXHL is worth the wait. ir.incannex.com/news-releases/…

#IncannexHealthcare is excited to share positive topline results from its #RePOSA Phase 2 #clinicaltrial evaluating IHL-42X, a novel oral drug candidate for #obstructivesleepapnea (OSA). Read more here: bit.ly/4l7kof8 #ClinicalTrials #SleepApnea #Incannex $IXHL #IXHL

Traumatic Brain Injury patent by $IXHL showcasing another one of the many cannabinoid pharmaceutical solutions in their pipeline. @ASX_IHL ppubs.uspto.gov/api/patents/ht…

$IXHL A couple of my thoughts after 6 to 7 years invested & why I think tonight is the start of pay week $IXHL reddit.com/r/INCANNEX_IXH…

$IXHL to finish green today & massive upside with top line phase 2 date delivered next week. Sleep Apnoea IHL-42X

#IncannexHealthcare announces the appointment of Charlene E. Gamaldo, M.D., to its IHL-42X #ObstructiveSleepApnea (OSA) Clinical Advisory Board. Read our full press release here: bit.ly/4m5HVOq $IXHL #Neurology #IXHL @HopkinsMedicine #SleepApnea

🚨 Another Positive Step for Incannex The recently published patent WO2025107039 — covering a fixed-dose capsule combining THC and acetazolamide — marks a critical advancement in Incannex’s IP strategy. This formulation underpins their lead candidate IHL-42X. $IXHL

#IncannexHealthcare announces the appointment of Douglas B. Kirsch, M.D., FAAN, FAASM, to its IHL-42X #ObstructiveSleepApnea (OSA) Clinical Advisory Board. Read more: bit.ly/3T2WAh1 $IXHL #SleepApnea

#IncannexHealthcare has achieved database lock for the RePOSA Phase 2 #clinicaltrial of IHL-42X, the Company’s lead drug candidate for #obstructivesleepapnea (OSA). Read the full press release here: bit.ly/4n9lHMU #Incannex $IXHL #sleepapnea

#IncannexHealthcare announces a 50:50 joint venture with @MindMedicineAU to operate a psychedelic-assisted therapies services clinic in Melbourne. Read the full press release: bit.ly/4e6IC7f #Incannex $IXHL

Another positive step forward by @ASX_IHL . Positioning itself for a juicey buyout. $IXHL nasdaq.com/press-release/…

$IXHL @ASX_IHL shaping up for a healthy buyout. I believe IHL-42X is the real deal & true value will soon be realised through a big pharmaceutical acquisition. reddit.com/r/INCANNEX_IXH…

Another vote of confidence for the company & its 42x sleep apnoea drug candidate. $IXHL. Well done.

It's worth reading some great contributions on $IXHL comparisons & potential valuations as $IXHL begins to re-rate upwards as news of a $RMD endorsement sinks in. reddit.com/r/INCANNEX_IXH…

$IXHL starting to heat up. 🔥

Some thoughts on why $IXHL Incannex could be valued at least 25 x today's SP & last night's announcement & endorsement by $RMD strengthened these thoughts. reddit.com/r/INCANNEX_IXH…